Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
$39.11
-1.0%
$32.42
$23.23
$42.29
$1.24B0.68413,800 shs447,830 shs
Neogen Corporation stock logo
NEOG
Neogen
$5.64
+0.7%
$5.11
$3.87
$17.95
$1.22B1.796.06 million shs2.90 million shs
Pharvaris N.V. stock logo
PHVS
Pharvaris
$23.12
-1.0%
$20.27
$11.51
$26.33
$1.21B-2.81142,735 shs53,502 shs
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
$3.00
$2.98
$0.55
$8.00
$302.52M-1.441.28 million shsN/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
-1.04%+3.63%+20.67%+35.52%+9.80%
Neogen Corporation stock logo
NEOG
Neogen
+0.71%+3.87%+11.46%-6.93%-65.50%
Pharvaris N.V. stock logo
PHVS
Pharvaris
-0.99%+3.68%+10.94%+44.59%+29.96%
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
2.1665 of 5 stars
1.50.00.03.02.70.81.3
Neogen Corporation stock logo
NEOG
Neogen
3.6529 of 5 stars
3.14.00.00.02.31.72.5
Pharvaris N.V. stock logo
PHVS
Pharvaris
2.6385 of 5 stars
3.44.00.00.03.30.80.0
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
3.00
Buy$42.338.24% Upside
Neogen Corporation stock logo
NEOG
Neogen
2.25
Hold$7.5032.98% Upside
Pharvaris N.V. stock logo
PHVS
Pharvaris
2.83
Moderate Buy$35.6053.98% Upside
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TLMD, NEOG, COLL, and PHVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2025
Neogen Corporation stock logo
NEOG
Neogen
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/18/2025
Pharvaris N.V. stock logo
PHVS
Pharvaris
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/13/2025
Pharvaris N.V. stock logo
PHVS
Pharvaris
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $52.00
8/11/2025
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$44.00
7/29/2025
Neogen Corporation stock logo
NEOG
Neogen
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
6/30/2025
Neogen Corporation stock logo
NEOG
Neogen
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $10.00
6/11/2025
Pharvaris N.V. stock logo
PHVS
Pharvaris
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$32.00
6/5/2025
Pharvaris N.V. stock logo
PHVS
Pharvaris
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$27.00
(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
$631.45M1.95$12.22 per share3.20$7.37 per share5.31
Neogen Corporation stock logo
NEOG
Neogen
$894.66M1.37$5.81 per share0.97$9.54 per share0.59
Pharvaris N.V. stock logo
PHVS
Pharvaris
N/AN/AN/AN/A$4.00 per shareN/A
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
$94.44M3.20N/AN/A$1.66 per share1.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
$69.19M$1.0437.616.50N/A5.13%97.28%13.87%11/6/2025 (Estimated)
Neogen Corporation stock logo
NEOG
Neogen
-$1.09B-$5.03N/A11.51N/A-122.06%2.39%1.57%10/9/2025 (Estimated)
Pharvaris N.V. stock logo
PHVS
Pharvaris
-$145.24M-$3.36N/AN/AN/AN/A-69.09%-63.34%N/A
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
-$50.54M-$0.57N/AN/A-53.52%-34.32%-20.96%N/A

Latest TLMD, NEOG, COLL, and PHVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Pharvaris N.V. stock logo
PHVS
Pharvaris
-$0.87-$0.94-$0.07-$0.94N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
N/AN/AN/AN/AN/A
Neogen Corporation stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
Pharvaris N.V. stock logo
PHVS
Pharvaris
N/AN/AN/AN/AN/A
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
3.27
1.18
1.10
Neogen Corporation stock logo
NEOG
Neogen
0.42
3.32
2.22
Pharvaris N.V. stock logo
PHVS
Pharvaris
N/A
8.33
8.33
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
0.52
3.32
3.28

Institutional Ownership

CompanyInstitutional Ownership
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
N/A
Neogen Corporation stock logo
NEOG
Neogen
96.73%
Pharvaris N.V. stock logo
PHVS
Pharvaris
N/A
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
N/A

Insider Ownership

CompanyInsider Ownership
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
2.51%
Neogen Corporation stock logo
NEOG
Neogen
1.13%
Pharvaris N.V. stock logo
PHVS
Pharvaris
11.84%
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
21031.50 million30.71 millionOptionable
Neogen Corporation stock logo
NEOG
Neogen
2,110217.21 million214.75 millionOptionable
Pharvaris N.V. stock logo
PHVS
Pharvaris
3052.29 million46.10 millionNot Optionable
SOC Telemed, Inc. stock logo
TLMD
SOC Telemed
226100.84 million93.88 millionOptionable

Recent News About These Companies

Comparative Studies in Society and History
Society Man
Mobile pet telehealth app expands offerings
Journal of the Royal Asiatic Society

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Collegium Pharmaceutical stock logo

Collegium Pharmaceutical NASDAQ:COLL

$39.11 -0.41 (-1.04%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$39.12 +0.01 (+0.01%)
As of 08/22/2025 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Neogen stock logo

Neogen NASDAQ:NEOG

$5.64 +0.04 (+0.71%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$5.74 +0.10 (+1.84%)
As of 08/22/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Pharvaris stock logo

Pharvaris NASDAQ:PHVS

$23.12 -0.23 (-0.99%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$23.18 +0.05 (+0.24%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. The company operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.

SOC Telemed stock logo

SOC Telemed NASDAQ:TLMD

SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's Telemed IQ, a cloud-based software platform provides telemedicine solutions. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, telecardiology, teleCritical Care (ICU), and other specialties. The company was founded in 2004 and is based in Herndon, Virginia. As of April 6, 2022, SOC Telemed, Inc. was taken private.